c-LEcta GmbH
Andreas Buthe is a seasoned professional with extensive experience in business development and research within the biotechnology and chemical industries. Currently serving as Vice President of Business Development at c-LEcta GmbH since September 2010, Andreas has held multiple leadership roles, including Head of Business Development and Head of Innovation. Previously, Andreas worked as a Research Associate at the Biotechnology Institute, University of Minnesota, where contributions included managing collaborations, developing grant proposals, and coordinating research projects. Earlier, as a Scientist at Ciba, Andreas focused on the strategic implementation of biotechnological processes and project management. Educational qualifications include studies at RWTH Aachen University and Heidelberg University.
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.